0.7243

2.91% -0.0217

After Hours: .72 -0.0043 -0.59%

Atyr Pharma Inc (ATYR)

Overview News Price History Discussions Forecast

Atyr Pharma Inc stock is traded at $0.7243, with a volume of 2.23M. It is down -2.91% in the last 24 hours and down -12.09% over the past month. aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

Previous Close:

$0.746

Open:

$0.7341

24h Volume:

2.23M

Relative Volume:

0.52

Market Cap:

$70.97M

Revenue:

Net Income/Loss:

P/E Ratio:

EPS:

Net Cash Flow:

1W Performance:

-2.78%

1M Performance:

-12.09%

6M Performance:

-86.36%

1Y Performance:

-81.76%

1-Day Range:

$0.7106

$0.76

1-Week Range:

$0.7106

$0.8503

52-Week Range:

$0.64

$7.2904

Atyr Pharma Inc Stock (ATYR) Company Profile

Name

Atyr Pharma Inc

Sector

Healthcare (1114)

Industry

Biotechnology (625)

Phone

(858) 731-8389

Address

10240 SORRENTO VALLEY ROAD, SAN DIEGO

Employee

Twitter

Next Earnings Date

2024-11-07

Latest SEC Filings

ATYR's Discussions on Twitter

Compare ATYR with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ATYR Atyr Pharma Inc	0.7243	73.10M	0	0	0	0.00
VRTX Vertex Pharmaceuticals Inc	468.38	113.87B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	776.54	80.22B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	406.40	52.56B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	803.74	49.31B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	175.07	37.37B	447.02M	-1.18B	-906.14M	-6.1812

Atyr Pharma Inc Stock (ATYR) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-16-25	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Sep-15-25	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Sep-15-25	Downgrade	H.C. Wainwright	Buy → Neutral
Sep-15-25	Downgrade	Leerink Partners	Outperform → Market Perform
Sep-15-25	Downgrade	Wells Fargo	Overweight → Equal Weight
Feb-18-25	Initiated	Leerink Partners	Outperform
Jan-06-25	Initiated	Cantor Fitzgerald	Overweight
Oct-04-24	Initiated	Wells Fargo	Overweight
Sep-05-24	Initiated	Jefferies	Buy
Jul-05-23	Downgrade	Oppenheimer	Outperform → Perform
Oct-12-21	Initiated	RBC Capital Mkts	Outperform
Sep-21-21	Initiated	Piper Sandler	Overweight
May-10-21	Initiated	Laidlaw	Buy
Aug-17-20	Upgrade	H.C. Wainwright	Neutral → Buy
Mar-04-20	Initiated	ROTH Capital	Buy
Mar-02-20	Initiated	Oppenheimer	Outperform
Feb-14-18	Downgrade	JP Morgan	Neutral → Underweight
Sep-07-17	Initiated	Piper Jaffray	Overweight
Dec-13-16	Downgrade	JP Morgan	Overweight → Neutral
Dec-16-15	Initiated	Citigroup	Neutral
Jun-01-15	Initiated	Citigroup	Buy
Jun-01-15	Initiated	JP Morgan	Overweight

View All

Atyr Pharma Inc Stock (ATYR) Latest News

Jan 06, 2026

Will aTyr Pharma Inc. (471A) stock beat Nasdaq index returns2026 world cup usa national team quarterfinals playmakers high defensive line expert forecast preview - Улправда

Jan 06, 2026

Dec 23, 2025

Class Action Lawsuit Filed: aTyr Pharma, Inc. (ATYR)Join by December 8, 2025Contact Levi & Korsinsky - The National Law Review

Dec 23, 2025

Dec 22, 2025

Is aTyr Pharma Inc. stock affected by interest rate hikesJuly 2025 Snapshot & Free Safe Entry Trade Signal Reports - Улправда

Dec 22, 2025

Dec 21, 2025

How aTyr Pharma Inc. stock reacts to inflationary pressures2025 Buyback Activity & Fast Momentum Stock Entry Tips - Улправда

Dec 21, 2025

ATyr Pharma, Inc.(NasdaqCM:ATYR) dropped from S&P Biotechnology Select Industry Index - marketscreener.com

Dec 21, 2025

Will aTyr Pharma Inc. stock remain a Wall Street favorite2025 Top Gainers & Technical Confirmation Alerts - Улправда

Dec 21, 2025

Dec 20, 2025

Winners Losers: Will aTyr Pharma Inc. stock remain a Wall Street favoriteWeekly Investment Recap & Accurate Entry/Exit Alerts - Улправда

Dec 20, 2025

Dec 19, 2025

Will aTyr Pharma Inc. stock outperform growth indexes2025 Investor Takeaways & Weekly Watchlist for Consistent Profits - Улправда

Dec 19, 2025

Will aTyr Pharma Inc. stock attract ESG investorsBear Alert & Verified Momentum Stock Alerts - Улправда

Dec 19, 2025

How aTyr Pharma Inc. stock benefits from tech adoption2025 Top Gainers & Free Growth Oriented Trading Recommendations - DonanımHaber

Dec 19, 2025

Why analysts raise outlook for aTyr Pharma Inc. (471A) stockExit Point & AI Forecast for Swing Trade Picks - DonanımHaber

Dec 19, 2025

Dec 18, 2025

Aug Fed Impact: How aTyr Pharma Inc. stock reacts to inflationary pressures2025 Growth vs Value & Daily Market Momentum Tracking - Улправда

Dec 18, 2025

Dec 15, 2025

Johnson Fistel Investigates Claims on Behalf of aTyr Pharma, Inc. (ATYR) Shareholders - marketscreener.com

Dec 15, 2025

aTyr Pharma, Inc. (NASDAQ:ATYR) Given Consensus Rating of "Hold" by Brokerages - MarketBeat

Dec 15, 2025

aTyr Pharma, Inc. (NASDAQ:ATYR) Given Consensus Rating of “Hold” by Brokerages - Defense World

Dec 15, 2025

Dec 09, 2025

Healthy Upside Potential: Atyr Pharma Inc (ATYR) - Setenews

Dec 09, 2025

Dec 08, 2025

ATYR Deadline: ATYR Investors with Losses Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit - Morningstar

Dec 08, 2025

ATYR Deadline: ATYR Investors with Losses Have Opportunity to Le - GuruFocus

Dec 08, 2025

Investors SueWallSt Over aTyr Pharma, Inc. Stock DropContact Levi & Korsinsky to Join - Louisiana First News

Dec 08, 2025

Shareholders that lost money on aTyr Pharma, Inc.(ATYR) - GlobeNewswire

Dec 08, 2025

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma - galvnews.com

Dec 08, 2025

ATYR DEADLINE ALERT: Hagens Berman Alerts aTyr Pharma - GlobeNewswire

Dec 08, 2025

ATYR LAWSUIT ALERT: The Gross Law Firm Notifies aTyr Pharma, Inc - GuruFocus

Dec 08, 2025

ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire

Dec 08, 2025

ATYR LAWSUIT ALERT: The Gross Law Firm Notifies aTyr Pharma, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - marketscreener.com

Dec 08, 2025

ATyr Pharma, Inc. Investigated for Securities Fraud ViolationsContact the DJS Law Group to Discuss Your RightsATYR - marketscreener.com

Dec 08, 2025

ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securi - GuruFocus

Dec 08, 2025

Dec 07, 2025

ATYR DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma - TMX Newsfile

Dec 07, 2025

Dec 06, 2025

ATYR Lawsuit: Hagens Berman Urges aTyr Pharma Investors to Act by Dec. 8 Deadline in Suit Over Trial Failure - GlobeNewswire

Dec 06, 2025

ATYR Lawsuit: Hagens Berman Urges aTyr Pharma Investors to Act by Dec. 8 Deadline in Suit Over Trial Failure - GlobeNewswire Inc.

Dec 06, 2025

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma - Newsfile

Dec 06, 2025

Dec 05, 2025

מועד אחרון לתביעה נגד ATYR: רוזן, משרד עורכי דין מוערך בעולם, מעודדים את משקיעי ATyr Pharma, Inc עם הפסדים של מעל מאה אלף דולר, להשיג ייעוץ לפני המועד החשוב של 8 בדצמבר בתביעה ייצוגית בניירות ערך - GlobeNewswire Inc.

Dec 05, 2025

ATYR DEADLINE MONDAY: ROSEN, A GLOBALLY RESPECTED LAW FIRM, - GlobeNewswire

Dec 05, 2025

aTyr Pharma Receives Nasdaq Deficiency Notice - TipRanks

Dec 05, 2025

Investors who lost money on aTyr Pharma, Inc.(ATYR) should contact Levi & Korsinsky about pending Class ActionATYR - cnhinews.com

Dec 05, 2025